La cadena de opciones muestra datos clave de las opciones de acciones de Humacyte a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Humacyte..

Humacyte (NASDAQ:HUMA) Bolsa, Cadena de Opciones

Humacyte

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

GameStop Corp.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BHIL

BSGM

CISO

CLEU

GDHG

HUMA

IMTE

NYXH

ORKA

PTPI

RAPP

SURG

THTX

TXMD

WINT

ZYBT

El premercado de hoy revela fuertes movimientos bursátiles tras informes financieros y aprobaciones clave en sectores críticos.

Las acciones de GameStop (GME) suben alrededor del 13%; Aquí están 20 acciones que se mueven en el premercado

AADI

APTO

CADL

CARA

MESO

MOBX

MTEM

NVNI

OCEA

PRFX

QUBT

ZCAR

FedEx sube un 8,7% con resultados sólidos y una nueva estrategia. Descubre otras acciones destacadas en premercado hoy.

Las acciones de FedEx (FDX) suben alrededor de un 9%; 20 acciones que se mueven en premercado

Earnings

Equities

Futures

Economics

Federal Reserve

Los futuros caen ante la &#34;Triple Brujería&#34; y nuevos datos de inflación. ¿Qué dicen los analistas sobre el mercado?

Futuros de EE.UU. caen antes de datos clave de inflación y Triple Brujería

Humacyte Inc

HUMAN PHEROMONE SCIENCE by Human Pheromone Sciences, Inc.

Human - United States Dollar

HUMAN HOLDINGS CO LTD by Human Holdings Co., Ltd.

Human Holdings Co Ltd

HUMAN UNITEC INTL INC by Human Unitec International, Inc.

Human Unitec International Inc

Humana Inc

Humanigen Inc

Humankind US Stock ETF

Humanscape

Humatech Inc

<a href="https://www.businessinsider.com/tesla-ramps-up-hiring-for-semi-truck-2025-4">https://www.businessinsider.com/tesla-ramps-up-hiring-for-semi-truck-2025-4</a>

General

TSLA

'Tesla adds over a thousand workers to jumpstart Semi truck production'- Business Insider

Goldman Sachs on Tuesday downgraded Avantor Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) from Buy to Neutral and lowered its <a href="https://www.benzinga.com/quote/AVTR/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $23 to $14</a>.
What Happened: Since being added to the Buy list on June 4, 2021, Avantor shares have plunged 60.1% versus the S&amp;P 500 +30.7 % and the XLV 13.5%, analyst Matthew Sykes explained.
&#8220;We had wrongly assumed that an aggressive cost savings program on the back of a segment reorganization and a bioprocessing business in recovery mode would be enough to continue to drive increased margin expansion and growth,&#8221; Sykes said.
Goldman Sachs&#8217; downgrade reflects broader macro and funding uncertainties.
&#8220;While we remain confident in the company's ability to expand margins, we are concerned that its Laboratory Solutions business will continue to be a drag on overall growth as competitive pressures intensify and macro headwinds persist,&#8221; analyst Sykes adds.
Last Friday, Avantor reported: 
<ul>
<li>Adjusted EPS of <a href="https://www.benzinga.com/general/health-care/25/04/45014623/avantor-sees-steady-earnings-plans-leadership-change-and-strategy-shift" target="_blank" rel="noreferrer noopener">23 cents in line with consensus</a>.</li>
<li>Sales of $1.58 billion, missing the <a href="https://www.benzinga.com/pressreleases/25/04/n45003264/avantor-reports-first-quarter-2025-results" target="_blank" rel="noreferrer noopener">consensus of $1.61 billion</a>.</li>
<li>Sales fell 6% compared to the first quarter of 2024. </li>
<li>Foreign currency translation had a negative impact of 1%, resulting in a sales decline of 2% on an organic basis.</li>
<li>Laboratory Solutions sales were $1.07 billion, a reported decrease of 8%. Sales decreased by 3% organically.</li>
<li>Bioscience Production sales were $516.4 million, a reported decrease of 1%, flat on an organic basis.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/45014623/avantor-sees-steady-earnings-plans-leadership-change-and-strategy-shift" rel="noreferrer noopener">Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift</a>
Why It Matters: Recent economic and policy changes had a notable impact on Avantor this quarter. Customers are cutting back on spending to save money. 
Although there are some encouraging signs of improvement in bioprocessing orders, the analyst is more concerned about Avantor's product mix, which hasn't held up as well as we expected.
Goldman sees valuation as supportive at these levels but less attractive than Buy-rated names in their coverage universe as the market looks for sustainable growth improvement.
On Monday, several analysts downgraded and lowered the price target for Avantor, including:
<ul>
<li>Baird maintained the Outperform rating for Avantor and lowered the price target from $21 to $17.</li>
<li>Morgan Stanley downgraded Avantor from Overweight to Equal-Weight and lowered the price target from $25 to $15.</li>
<li>Barclays maintained Avantor with an Overweight, lowering the price target from $18 to $15.</li>
<li>Stifel downgraded Avantor from Buy to Hold and lowered the price target from $26 to $14.</li>
<li>RBC Capital maintained Avantor with an Outperform, lowering the price target from $24 to $20.</li>
</ul>
Price Action: Avantor stock is up 0.8% at $12.59 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/45075714/novartis-q1-earnings-beat-street-view-ceo-confident-to-deliver-upgraded-2025-guidance" target="_blank" rel="noreferrer noopener">Novartis Q1 Earnings Beat Street View, CEO &#8216;Confident&#8217; In Delivering Upgraded Guidance</a></li>
</ul>
Image: Shutterstock

Analyst Color

Guidance

Downgrades

Health Care

Analyst Ratings

AVTR

Goldman Sachs Downgrades Avantor As Shares Spiral 60% Since 2021: 'We Wrongly Assumed...'

WIIM

Cantor Equity Partners shares are trading higher on continued strength after entering into a business combination agreement with Twenty One Capital.

HSBC Holdings, Plc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSBC#NYSE">HSBC</a>) shares traded higher on Tuesday after the company <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">reported&nbsp;first-quarter&nbsp;results</a>.
Revenue decreased 13%&nbsp;year over year (Y/Y) to&nbsp;$17.6 billion due to business divestments, mainly in Canada and Argentina.
Constant currency revenue, excluding notable items, increased 7% Y/Y to $17.7 billion. Banking net interest income (NII) declined to $10.6 billion&nbsp;from&nbsp;$10.9 billion&nbsp;in the quarter.
Customer loans stood at&nbsp;$945 billion, and deposits came in at&nbsp;$1.67 trillion. At the end of the quarter, the CET1&nbsp;ratio was&nbsp;14.7%.
The company's expected credit losses stood at&nbsp;$0.9 billion&nbsp;in&nbsp;the first quarter of 2025.
Adjusted EPS of $1.95, up from <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">$1.70 a year ago quarter</a>.
Buyback: On April 25, HSBC completed a $2 billion share buyback announced alongside its full-year 2024 results.
The bank intends to initiate a share buyback of up to $3 billion, which is expected to start shortly after the annual general meeting on May 2 2025 and to be completed within the period before the 2025 interim results announcement.
Outlook: For FY25, HSBC continues to target banking NII of around&nbsp;$42 billion&nbsp;and mid-teens return on average tangible equity in&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">each of the three years from 2025 to 2027</a>.
The bank aims to target cost factors in savings from the reorganization, expecting&nbsp;$0.3 billion&nbsp;in reductions in 2025 and an annualized&nbsp;<a target="_blank" href="https://www.benzinga.com//node/43825656" rel="noreferrer noopener">$1.5 billion&nbsp;cut by the end of 2026</a>.&nbsp;
HSBC says that achieving this will require&nbsp;$1.8 billion&nbsp;in severance and other upfront costs over 2025-2026.&nbsp;The bank anticipates Expected Credit Loss (ECL) charges between 30-40 basis points in 2025.
HSBC foresees muted lending growth but strong growth in its Wealth business while maintaining a stable Common Equity Tier 1 (CET1) ratio.
Investors can gain exposure to the stock via Precidian ETFs Trust HSBC Holdings plc ADRhedged (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSBH#NYSE">HSBH</a>) and Elevation Series Trust The Opal International Dividend Income ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IDVZ#BATS">IDVZ</a>).
Price Action: HSBC shares are up 2.29% at $57.63 at the last check Tuesday.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com//node/45033865" target="_blank" rel="noreferrer noopener">Trump's Tariff Policies Fuel Recession Fears As Millennials Coach Gen Z On Financial Survival</a></li>
</ul>
Photo by TungCheung via Shutterstock

Asia

Large Cap

HSBC

HSBH

Elevation Series Trust The Opal International Dividend Income ETF

IDVZ

Why Is HSBC Stock Trading Higher On Tuesday?

Wave Life Sciences shares are trading higher after Cantor Fitzgerald initiated coverage with an Overweight rating and $10 price target.

The U.S. Food and Drug Administration on Tuesday approved AbbVie Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) Rinvoq (upadacitinib), 15 mg, once daily, for <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">giant cell arteritis (GCA)</a>.
GCA is an inflammation of blood vessels, called arteries, in and <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n45063491/rinvoq-upadacitinib-receives-u-s-fda-approval-for-giant-cell-arteritis-gca" rel="noreferrer noopener">around the scalp</a>.
Earlier in April, the European Commission approved Rinvoq for giant cell arteritis <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44678235/abbvie-announces-european-commission-approval-of-rinvoq-upadacitinib-for-the-treatment-of-adults-w" rel="noreferrer noopener">in adult patients</a>.
<ul>
<li>Rinvoq is the first and only oral JAK inhibitor approved in the EU,  Iceland, Liechtenstein and Norway for adult patients with GCA.</li>
</ul>
The approvals are supported by the pivotal Phase 3 SELECT-GCA clinical trial results, which met the primary endpoint of sustained remission.
<ul>
<li>46.4% of patients receiving Rinvoq 15 mg in combination with a 26-week steroid taper regimen achieved sustained remission from week 12 to week 52, compared to 29.0% of patients receiving placebo in combination with a 52-week steroid taper regimen; p=0.002.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44937940/abbvies-pipeline-may-be-a-2026-story-but-analyst-likes-the-setup-now" rel="noreferrer noopener">AbbVie&#8217;s Pipeline May Be A 2026 Story, But Analyst Likes The Setup Now</a>
On Friday,&nbsp;AbbVie reported an adjusted EPS of $2.46, up 6.5% year over year and beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $2.38</a>.
<ul>
<li>The pharmaceutical giant reported sales of $13.34 billion, up 8.4% on a reported basis (+9.8% on an operational basis), beating the&nbsp;<a href="https://www.benzinga.com/25/04/45011116/abbvie-q1-earnings-come-ahead-of-expectations-ceo-says-well-positioned-for-long-term" target="_blank" rel="noreferrer noopener">consensus of $12.92 billion</a>.</li>
<li>It reported adjusted earnings per share of $2.46, beating the street view of $2.38.</li>
<li>In the first quarter of 2025, Rinvoq sales reached $1.72 billion, an increase of 57.2% (+59.7%).</li>
<li>BMO Capital Markets on Monday wrote that every quarter seems to tell the same story. Analysts think they've accurately factored in Skyrizi and Rinvoq's growth, only for AbbVie to outperform <a href="https://www.benzinga.com/25/04/45050728/abbvies-immunology-portfolio-poised-to-continue-growing-through-humira-erosion-analyst" target="_blank" rel="noreferrer noopener">expectations once again</a>.</li>
</ul>
Last Thursday, AbbVie&nbsp;submitted a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44977545/abbvie-submits-biologics-license-application-to-u-s-fda-for-trenibotulinumtoxine-trenibote-for-the" rel="noreferrer noopener">Biologics License Application</a> to the FDA for trenibotulinumtoxinE (TrenibotE) for moderate to severe glabellar lines (commonly known as frown lines).
<ul>
<li>TrenibotE is a first-in-class botulinum neurotoxin serotype E characterized by a rapid onset of action as early as eight hours after administration (earliest assessment time) and a shorter duration of effect of two to three weeks. </li>
</ul>
ABBV Price Action: AbbVie stock is up 1.31% at $194.95 at publication Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/45075714/novartis-q1-earnings-beat-street-view-ceo-confident-to-deliver-upgraded-2025-guidance" target="_blank" rel="noreferrer noopener">Novartis Q1 Earnings Beat Street View, CEO &#8216;Confident&#8217; In Delivering Upgraded Guidance</a></li>
</ul>

Biotech

ABBV

AbbVie Scores FDA Approval For Its Blockbuster Drug Rinvoq To Treat Type of Arthritis

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is hovering near a major resistance level around $95,000. Analysts expect the upcoming Core PCE inflation report on Wednesday to be a potential catalyst that could push the apex crypto <a href="https://www.benzinga.com/money/bitcoin-price-prediction">to new all-time highs.</a>
What Happened: In a <a href="https://www.youtube.com/watch?v=frtgrhyme6Q&amp;ab_channel=KevCapitalTA">podcast</a> on April 29, technical analyst Kevin highlighted a technical confluence near the $94,410–$95,581 range, where Bitcoin has temporarily paused after a 30% surge from recent lows. 
"We're at the golden pocket, a major volume node, and the point of control," Kevin said, emphasizing the significance of the current level.
A close above the bull market support band, made up of the 20-week simple moving average and 21-week exponential moving average, adds bullish momentum. 
Still, he cautions that short-term consolidation or a pullback remains possible before the next leg higher.
If Bitcoin retraces, Kevin sees $88,000–$90,000 as a strong support zone, aligning with the 0.5 Fibonacci retracement level, key moving averages and a CME gap near $91,600, which "fill 90+% of the time," adding further credibility to a potential revisit.
Inflation Catalyst
Kevin flagged Wednesday's Core PCE release, the Fed's preferred inflation gauge, as a potential inflection point.
Forecasts expect the number to drop from 0.4% to 0.1%. A cooler-than-expected print could heighten expectations for rate cuts, a move historically supportive of Bitcoin and broader crypto assets.
&#8220;If we get a positive core PCE index number and it&#8217;s much lower than expected, the market is going to start sniffing out rate cuts coming by the Fed," Kevin added noting that monetary easing has been a key driver for crypto markets throughout this cycle.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45048427/watch-this-bitcoin-indicator-to-know-if-a-run-to-100000-is-coming">Watch This Bitcoin Indicator To Know If A Run To $100,000 Is Coming</a>
What's Next: Kevin advises traders who went long near recent lows to consider hedging, rather than fully exiting positions. 
"If you want some downside exposure, there's nothing wrong with a small, short here," he said, noting that such a move could offer protection while maintaining upside exposure.
He also points to a decline in USDT dominance, now hitting its bull market support band and 200-day EMA, as a bullish signal for crypto. 
Negative money flow in USDT dominance suggests any uptick could be short-lived, further supporting continued momentum in Bitcoin.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45076518/bitcoin-is-a-commodity-like-gold-says-commerce-secretary-lutnick">Bitcoin Is A Commodity Like Gold, Says Commerce Secretary Lutnick</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Glued To $95,000 But Wednesday Inflation Data Could Spur A Breakout

WOLF

Wolfspeed shares are trading lower, paring back gains from a sharp rally over the past week.

Leggett & Platt shares are trading higher Tuesday. The company on Monday reported better-than-expected Q1 EPS results and raised its FY25 EPS guidance.

Intel&nbsp;Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)&nbsp;told Reuters on Tuesday that several contract manufacturing customers planned to <a target="_blank" href="https://www.benzinga.com/topic/intel" rel="noreferrer noopener">build test chips</a> for its forthcoming advanced manufacturing process as it struggled to win market share from &nbsp;Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>).
The chipmaker&#8217;s new 14A technology will follow 18A, which is scheduled to go into production in the second half of 2025, Intel <a href="https://www.bloomberg.com/news/articles/2025-04-29/intel-says-customers-preparing-to-test-new-production-technology?sref=TBDibEcD" target="_blank" rel="noopener">told</a> Bloomberg ahead of its Foundry Direct Connect event on Tuesday. At the event, <a href="https://www.benzinga.com/pressreleases/25/04/b45074209/intel-foundry-gathers-customers-and-partners-outlines-priorities" target="_blank" rel="noreferrer noopener">Intel Foundry Direct Connect</a> will share progress on multiple generations of its core process and advanced packaging technologies.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/25/04/45008023/intel-weighs-taiwan-semiconductor-partnership-to-boost-chip-game" rel="noreferrer noopener">Intel Weighs Taiwan Semiconductor Partnership To Boost Chip Game</a>
It will also announce new ecosystem programs and partnerships and welcome industry leaders to discuss how a systems foundry approach enables collaboration with partners and unlocks innovation for customers. Intel CEO Lip-Bu Tan will open the event by discussing Intel Foundry&#8217;s progress and priorities as the company drives the next phase of its Foundry strategy. 
Intel told Bloomberg that multiple customers intend to build test chips on the new process node.
CEO Tan shared plans to leverage his relationships in the chip industry to win clients for custom chipmaking.
After assuming charge in March 2025, Tan vowed to reshape Intel, including revamping the company&#8217;s foundry operation.
Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)&nbsp;and Nvidia&nbsp;Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) have reportedly run tests for Intel&#8217;s current advanced manufacturing process, 18A.
Intel reiterated it was planning to ramp up the 18A process to high-volume production in 2025, Reuters reported Tuesday. It plans to manufacture chips with 18A initially at its research and development lab near Hillsboro, Oregon. The company&#8217;s factories in Arizona will ramp up production this year.
Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) senior vice president John Koeter emphasized the successful collaboration between Synopsys and Intel Foundry is advancing the semiconductor industry with silicon-to-system design solutions to meet the evolving needs for AI and high-performance computing applications.
Price Actions:&nbsp;At the last check Tuesday, INTC stock was down 0.46% to $20.43.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/04/45050460/whats-pushing-sony-to-consider-a-semiconductor-spinoff" target="_blank" rel="noreferrer noopener">What&#8217;s Pushing Sony To Consider A Semiconductor Spinoff?</a></li>
</ul>
Photo: Shutterstock

Tech

Media

AVGO

INTC

NVDA

SNPS

Intel Ramps Up New Chip Tech To Take On Taiwan Semiconductor's Global Lead

JinkoSolar Holding Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JKS#NYSE">JKS</a>) stock slipped on Tuesday after the company posted <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n45063870/jinkosolar-announces-first-quarter-2025-financial-results" rel="noreferrer noopener">mixed first-quarter 2025 results</a>.
The solar module manufacturer&#8217;s revenue decreased 39.9% year-over-year to $1.908 billion, beating the analyst consensus estimate of $1.89 billion. Adjusted loss per ADS of $2.86 missed the analyst consensus loss estimate of $1.38.
Quarterly shipments totaled 19,130 MW—comprising 17,504 MW of solar modules and 1,626 MW of cells and wafers—representing a 12.7% decline compared to last year.
First-quarter 2025 module shipments reached 17.5 GW, the highest in the industry.
The company posted a gross loss of RMB352.9 million ($48.6 million), with the margin falling to -2.5% due to lower solar module prices, compared to 11.9% a year earlier.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/04/44925565/first-solar-stock-jumps-as-u-s-finalizes-tariffs-on-southeast-asian-solar-panels" rel="noreferrer noopener">First Solar Stock Jumps as U.S. Finalizes Tariffs on Southeast Asian Solar Panels</a>
Operating loss rose to RMB2.87 billion ($394.8 million), up from RMB339.6 million a year ago. Operating loss margin widened to –20.7%, compared to –1.5% a year ago.
As of March 31, 2025, the company had RMB27.38B ($3.77B) in cash, RMB12.79B in receivables, RMB13.26B in inventory, and RMB46.54B in debt.
As of March 31, 2025, the company had RMB27.38 billion ($3.77 billion) in cash, RMB12.79 billion in receivables, RMB13.26 billion in inventory, and RMB46.54 billion in debt.
JinkoSolar&#8217;s 2025 order visibility stands at 60–70% overall, surpassing 80% in the Indo-Pacific and MEA regions. Its N-type TOPCon tandem solar cell set a new efficiency record of 34.22%.
Q2 Guidance: JinkoSolar expects module shipments to range between 20.0 GW and 25.0 GW, reflecting current market demand and order visibility.
2025 Outlook: Module shipments are projected between 85.0 GW and 100.0 GW.
Annual production capacity is expected to reach 120.0 GW for mono wafers, 95.0 GW for solar cells, and 130.0 GW for modules by year-end.
&#8220;Prices across the main segments of the solar industrial chain were low in the first quarter. This, combined with disruptions in demand caused by changes in international trade policies, pressured profit margins in each segment of the integrated solar supply chain. Despite this challenging market environment, we fulfilled our delivery commitments to customers and reduced costs through supply chain optimization, adjustments to production and operation plans, and other measures,&#8221; commented Mr.&nbsp;Xiande Li,&nbsp;JinkoSolar&#8217;s&nbsp;Chairman and Chief Executive Officer
&#8220;Due to a year-over-year decline in shipments to the U.S. market and a continued decline in higher-price overseas orders, our module prices and profitability decreased both year-over-year and sequentially.&#8221;
Price Action: JKS stock traded lower by 6.43% at $16.52 at the last check on Tuesday.
Photo by Robert Way via Shutterstock

JinkoSolar Blames Trade Policy Uncertainty For Demand Disruption, Margin Pressure

IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) shares edged higher on Tuesday as the company raised its quarterly dividend and unveiled a new <a href="https://www.benzinga.com/pressreleases/25/04/b45077011/box-and-ibm-partner-to-bring-new-enterprise-level-ai-models-to-support-content-generation-and-prod" target="_blank" rel="noreferrer noopener">AI-focused collaboration with </a><a href="https://www.benzinga.com/pressreleases/25/04/b45077011/box-and-ibm-partner-to-bring-new-enterprise-level-ai-models-to-support-content-generation-and-prod" target="_blank" rel="noreferrer noopener">Box Inc.</a><a href="https://www.benzinga.com/pressreleases/25/04/b45077011/box-and-ibm-partner-to-bring-new-enterprise-level-ai-models-to-support-content-generation-and-prod" target="_blank" rel="noreferrer noopener"> </a>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>).
IBM bumped up its regular quarterly cash dividend to $1.68 per share, scheduled for payment on June 10, 2025, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n45069845/ibm-board-approves-increase-in-quarterly-cash-dividend-for-the-30th-consecutive-year" rel="noreferrer noopener">to shareholders on record as of May 9.</a>
This marks the 30th consecutive year the tech giant has raised its dividend, maintaining a streak of uninterrupted payouts since 1916.
IBM also announced a strategic expansion of its partnership with Box to advance enterprise-grade artificial intelligence adoption.
Also Read:<a target="_blank" href="http://benzinga.com/news/large-cap/25/04/45041909/ibm-commits-30-billion-to-rd-in-us-eyes-next-level-advances-in-mainframes-and-quantum-computing" rel="noreferrer noopener"> IBM Commits $30 Billion To R&amp;D In US, Eyes Next-Level Advances In Mainframes And Quantum Computing</a>
The effort centers on integrating Box AI with IBM&#8217;s watsonx platform to boost productivity through intelligent content management across highly regulated sectors.
The integration enables Box customers to deploy Box AI enhanced by IBM&#8217;s watsonx.ai tools, including access to IBM&#8217;s open-source Granite models and Meta&#8217;s Llama models.
This aims to streamline tasks like document automation, data extraction,= and content analysis, helping organizations unlock insights from unstructured enterprise data.
IBM itself has adopted Box AI internally, embedding the tools into its employee workflows.
Meanwhile, Box has implemented IBM&#8217;s watsonx.governance to oversee its AI lifecycle, ensuring compliance and transparency. The company continues to rely on Red Hat OpenShift, also under IBM&#8217;s umbrella, for agile cloud deployment of its AI tools.
The companies emphasized the importance of responsible AI. &#8220;We&#8217;re empowering enterprises to harness AI responsibly and at scale,&#8221; said Aaron Levie, Box&#8217;s CEO.
Rob Thomas, IBM&#8217;s senior vice president of Software, highlighted the partnership&#8217;s goal to embed AI seamlessly into operational workflows to enhance productivity.
The Box AI with IBM watsonx solution is now available to Box Enterprise Advanced customers through Box AI Studio and APIs.
IBM is a certified reseller of Box offerings that include AI functionality, providing clients direct access to IBM&#8217;s enterprise AI model family.
IBM Price Action: IBM shares are trading higher by 1.40% to $239.46 at publication Tuesday.
Read Next:
<ul>
<li><a href="http://benzinga.com/trading-ideas/25/04/45050322/how-youll-know-the-tariff-troubles-are-over" target="_blank" rel="noreferrer noopener">How You&#8217;ll Know When Tariff Troubles Are Finally Over</a></li>
</ul>
Photo: Shutterstock

Dividends

What's Going On With IBM Stock Today?

PACCAR Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) shares are trading lower on Tuesday after it<a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45064199/paccar-achieves-good-financial-performance-and-record-paccar-parts-revenue" rel="noreferrer noopener"> reported first-quarter results.</a>
The company reported quarterly adjusted earnings per share of $1.46, missing the analyst consensus estimate of $1.59.
Quarterly sales of $6.91 billion (down 16% year over year) missed the street view of $7.17 billion.
Harrie Schippers, president and chief financial officer, said, &#8220;PACCAR is making good progress on substantially resolving the EU civil litigation.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45066479/rare-bullish-signal-just-flashed-on-wall-street-will-it-power-sp-500-to-6000" rel="noreferrer noopener">Rare Bullish Signal Just Flashed On Wall Street: Will It Power S&amp;P 500 To 6,000?</a>
PACCAR Parts achieved quarterly pretax income of $426.5 million, compared to $455.8 million earned in the first quarter of 2024.&nbsp;
The company has produced 1.2 million PACCAR MX engines, leading to a downstream powertrain business opportunity in remanufactured engines. &#8220;PACCAR is investing in a 50,000 sq. ft., $35 million PACCAR engine remanufacturing facility in Columbus, Mississippi,&#8221; shared Harry Wolters, PACCAR vice president.
PACCAR said it is increasing its investment in next generation internal combustion, hybrid and battery-electric powertrains, integrated connected vehicle services, expanded manufacturing capabilities, and advanced driver assistance systems.
The company&#8217;s capital expenditures are projected to be in the range of $700-$800 million and research and development expenses are estimated to be in the range $450-$480 million in 2025.&nbsp;&nbsp;
In addition to the capital and R&amp;D investments, the company said it plans to invest a total project amount of $600-$900 million in its battery joint venture, Amplify Cell Technologies.
The company&#8217;s cash and cash equivalents at end of quarter was $5.517 billion.
PACCAR said that the North American truck market is being affected by uncertain economic conditions and the impact of new tariffs.
U.S. and Canada Class 8 truck industry retail sales are estimated to be in a range of 235,000-265,000 trucks in 2025.
Price Action: PCAR shares are trading lower by 3.36% to $88.95 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/45029759/cramers-warning-tariff-chaos-could-derail-tech-earnings-frenzy-this-week" target="_blank" rel="noreferrer noopener">Cramer&#8217;s Warning: Tariff Chaos Could Derail Tech Earnings Frenzy This Week</a></li>
</ul>
Image: Shutterstock

PCAR

PACCAR Misses Q1 Earnings, Blames Tariff Turmoil For Hitting North American Truck Market

In November 2017, Lamborghini gifted Pope Francis a one-of-a-kind Huracán. The <a href="https://www.benzinga.com/news/25/02/43759368/silicon-valley-millionaire-asks-dave-ramsey-if-he-should-buy-a-250000-lamborghini-heres-what-car-nut-ramsey-always-asks-himself">sleek white supercar</a>, detailed with gold stripes along the hood and body, was presented to the pope outside his residence at Casa Santa Marta in Vatican City.
Instead of keeping the luxury ride, Pope Francis blessed and autographed it, then decided to auction it off for charity. By May 2018, the Lamborghini sold at Sotheby&#8217;s in London for an impressive $950,000.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.</li>
</ul>
<h2 class="wp-block-heading">Helping Rebuild After ISIS Destruction</h2>
According to the <a href="https://www.catholicnewsagency.com/news/246695/how-pope-francis-used-a-donated-lamborghini-to-help-rebuild-iraqi-christian-communities">Catholic News Agency</a>, the proceeds from the auction were split between several charitable causes personally selected by the pope. A significant portion — about $240,000 — went to Aid to the Church in Need, which used the funds to rebuild parts of Iraq&#8217;s Nineveh Plains devastated by ISIS.
Alessandro Monteduro, director of Aid to the Church in Need Italia, said, &#8220;With the two projects described, Aid to the Church in Need wanted to honor the donation of the Holy Father by concretely placing itself alongside the Christians attacked by ISIS.&#8221;
Pope Francis allocated the rest of the proceeds to other humanitarian causes. Donations were made to support victims of human trafficking through the Pope John XXIII Community, and to fund medical and missionary work in Africa through GICAM and Friends of Central Africa.
Trending: Donald Trump Just Announced a $500 Billion AI Infrastructure Deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">Here's How You Can Invest in the Entertainment Market's Next Big Disruptor for Just $998</a>
<h2 class="wp-block-heading">The Internet Reacts: &#8220;There&#8217;s Someone Out There With A Popeborghini&#8221;</h2>
When the story resurfaced online, <a href="https://www.reddit.com/r/interestingasfuck/comments/1k5qfry/pope_francis_in_november_2017_receiving_a_custom/">Reddit</a> users had a field day. &#8220;So there's someone out there with a Popeborghini?&#8221; one comment joked, earning more than 23,000 upvotes.
Another quipped, &#8220;It just doubled in value,&#8221; now that the <a href="https://www.benzinga.com/25/04/44916290/pope-francis-the-peoples-pope-dies-at-88-tributes-pour-in-from-trump-king-charles-tim-cook-joe-biden-jimmy-fallon-and-more">pope has passed away</a>, while others imagined the pope doing donuts in the Vatican parking lot at the time. Some pointed out the symbolism of the sale, saying Pope Francis, &#8220;wants for nothing and it&#8217;s not worth the public scrutiny to accept&#8221; such extravagant gifts.
The humor flowed freely, but many users also expressed genuine admiration for Francis&#8217; decision to turn an ultra-luxury gift into a powerful act of charity.
See Also: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
<h2 class="wp-block-heading">Not the First Time</h2>
Pope Francis has made a habit of auctioning off high-end gifts for good causes. In 2013, he sold a Harley-Davidson Dyna Super Glide he had received, fetching about $327,000 for charity, far more than the bike's original value.
Other popes have done similar things. Ferrari once gifted the final Enzo ever made to Pope John Paul II, who declined to keep it. The car was auctioned off to aid victims of the 2004 South Asian tsunami.
Pope Francis&#8217; Lamborghini Huracán wasn&#8217;t just a flashy headline — it resulted in real help for communities desperately trying to rebuild their lives.
&#8220;The pope doesn&#8217;t drive,&#8221; one Reddit user joked. But in this case, he drove something far more important: change.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
Image: Shutterstock

In 2017, Lamborghini Gave Pope Francis A Custom Supercar Valued At $950,000. Here's What He Did With It

Domino&#8217;s Pizza Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) reported the <a href="https://www.benzinga.com/news/25/04/45039495/dominos-pizza-q1-operating-margin-shrinks-as-lower-income-consumers-feel-the-pinch">first-quarter FY25 earnings </a>on Monday. Several analysts have provided their opinion on the pizza restaurant chain&#8217;s performance.
BofA Securities analyst Sara Senatore reiterated a Buy rating on the shares and raised the price forecast from $520.00 to $549.00.
Despite Domino's weaker-than-expected Q1 domestic same-store sales growth (SSSG), results aligned with internal plans, including share gains in the QSR pizza segment, said the analyst.
She expects performance to accelerate with innovations like stuffed crust and the DoorDash partnership. Supply chain productivity and sales leverage are seen supporting EBIT growth.
FY25 EPS is raised on stronger SSSG, while second-quarter EPS is trimmed due to a higher tax rate.
RBC Capital Markets analyst Logan Reich reiterated an &#8220;Outperform&#8221; rating on the shares and raised the price target from $500 to $550.
Domino&#8217;s first-quarter results were mixed. International same-store sales (SSS) beat expectations, and U.S. market share gains continued despite consumer headwinds, noted the analyst.
Also Read: <a href="https://www.benzinga.com/news/25/04/45074719/levi-strauss-shareholders-stand-by-dei-policy-amid-political-pushback">Levi Strauss Shareholders Stand By DEI Policy Amid Political Pushback</a>
Japan&#8217;s store closures are mostly complete, and FY25 guidance for SSS, unit growth, and 8%+ EBIT growth (FXN) was reiterated. However, broader category weakness persists, especially among low-income consumers, noted the analyst.
Benchmark analyst Todd Brooks reiterated a Buy rating on the shares and raised the price forecast from $520 to $535.
Domino's expects U.S. same-store sales (SSS) to accelerate in 2H25 and into FY26, driven by two key initiatives: the successful launch of stuffed crust pizza and the upcoming DoorDash rollout, expected to add up to 300bps to SSS.
Management maintained FY25 U.S. SSS guidance at 3%, citing strong value positioning, effective promotions like the &#8220;$9.99 Best Deal Ever,&#8221; and ongoing share gains in both delivery and carryout channels, the analyst opined.
BMO Capital analyst Andrew Strelzik reiterated an &#8220;Outperform&#8221; rating on the shares and raised the price target from $515 to $540.
Domino's U.S. same-store sales (SSS) declined 0.5% in the first quarter, missing expectations due to macro headwinds and tough comparisons, though the company still gained market share.
International SSS rose 3.7%, beating consensus with strength in India and Canada. U.S. comps are expected to accelerate through 2025, driven by the launch of Stuffed Crust and the rollout of DoorDash.
Management reiterated its unit growth guidance and expects minimal impact from tariffs on development.
Price Action: DPZ shares traded higher by 0.19% at $491.56 at last check Tuesday.
Read Next: <a href="https://www.benzinga.com/news/25/04/45069925/coca-cola-boasts-q1-eps-beat-as-revenue-jumps-in-europe-middle-east-and-africa">Coca-Cola Boasts Q1 EPS Beat As Revenue Jumps In Europe, Middle East And Africa</a>
Photo: Shutterstock

Domino's Pizza Will Grow With Stuffed Crust & DoorDash Partnership, Say Analysts

Editor&#8217;s Note: An April 23 version of this SolarBank story has been deleted.

Exclusives

SUUN

April 23 SolarBank Story Has Deleted (CORRECTED)

<a href="https://x.com/lisadnews/status/1917278870912254330?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/lisadnews/status/1917278870912254330?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a>

PBS Correspondent Lisa Desjardins On X Posts "U.S. Trade Rep Greer told GOP senators that countries are coming to the table on tariff talks, but Europe is not engaging as well."

Shares of D-Wave Quantum Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) fell 4.5% to $7.03 during Tuesday's trading after Kerrisdale Capital released a <a href="https://www.kerrisdalecap.com/wp-content/uploads/2025/04/Dwave-Kerrisdale.pdf">report</a> questioning the company's business fundamentals and long-term viability. Benzinga reached out to D-Wave for comment but has not received a response.
What To Know: The short seller said D-Wave's quantum annealing technology is a niche solution with limited commercial relevance and growing obsolescence compared to gate-model quantum systems favored by peers like IBM and Google. 
Kerrisdale <a href="https://www.kerrisdalecap.com/wp-content/uploads/2025/04/Dwave-Kerrisdale.pdf">highlighted</a> that despite over a decade of operations, D-Wave has never generated more than $9 million in recurring annual revenue, and its 2024 revenues were flat year-over-year.
Read Also: <a href="https://www.benzinga.com/news/25/04/45074299/wolfspeed-wolf-stock-plunges-after-explosive-77-rally-whats-going-on">Wolfspeed Stock Plunges After Explosive 77% Rally: What&#8217;s Going On?</a>
The report characterizes D-Wave's hybrid solutions—which combine classical and quantum computing—as largely classical in nature, citing interviews with former employees who alleged the quantum component offers little to no practical advantage. 
Kerrisdale also questioned the company's recent <a href="https://www.benzinga.com/content/44345924/d-wave-quantum-stock-jumps-on-quantum-supremacy-news">"quantum supremacy"</a> announcement, suggesting the benchmark was a custom-tailored, academically interesting but commercially irrelevant problem.
With shares trading at 57x consensus 2026 revenue estimates, Kerrisdale described the current valuation as unsustainable and driven by hype rather than fundamentals. 
While D-Wave has announced a pivot toward gate-model quantum computing, the report also noted a lack of progress or credible roadmap in that direction.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/04/45073201/plug-power-stock-is-trending-tuesday-whats-going-on">Plug Power Stock Is Trending Tuesday: What&#8217;s Going On?</a>
<h2 class="wp-block-heading">How To Buy QBTS Stock</h2>
By now you're likely curious about how to participate in the market for D-Wave Quantum &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of D-Wave Quantum, which is trading at $7.03 as of publishing time, $100 would buy you 14.2 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, QBTS has a 52-week high of $11.95 and a 52-week low of $0.75.

QBTS

D-Wave Quantum (QBTS) Stock Falls Amid Valuation Critique By Kerrisdale Capital

Wall Street rose modestly by midday Tuesday, as investors weighed the latest developments in trade negotiations and awaited a wave of key economic data and corporate earnings set for <a href="https://www.benzinga.com/25/04/45072497/us-trade-deficit-explodes-to-record-162-billion-in-march-as-import-frenzy-precedes-trumps-tariff-barrage">release later this week.</a>
President Donald Trump is <a href="https://apnews.com/article/trump-tariffs-automakers-factories-relief-25a400c98e02c01c8c54502384e267e1">expected</a> to unveil a new executive order on auto tariffs later today. Meanwhile, U.S. Treasury Secretary Bessent added that the administration is pursuing bilateral trade agreements with 17 major partners, excluding China.
The S&amp;P 500 climbed 0.4%, putting it on track for a sixth consecutive gain—its longest winning streak since November 2024.
In the bond market, U.S. Treasuries extended their rally, with yields falling for a sixth straight session. The yield on the 10-year benchmark dropped to 4.17%, marking a two-week low.
Gold prices slipped 0.6% to $3,325 per ounce, while WTI crude oil futures fell 2.4% to $60 per barrel, the lowest level in two weeks. Oil prices are under pressure from escalating global trade tensions and weaker U.S. economic data, and crude is now on track for a 15% decline in April—its steepest monthly drop since 2021.
Bitcoin traded little changed, around $95,000.
<h3 class="wp-block-heading">Tuesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg</td>
<td>1-day %</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,513.32</td>
<td>+285.73</td>
<td>0.7%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,548.89</td>
<td>+20.14</td>
<td>0.4%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,468.38</td>
<td>+41.09</td>
<td>0.2%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,969.38</td>
<td>+3.83</td>
<td>0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:40 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.4% up to $552.91.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.7% to $404.9.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;edged 0.3% higher to $473.78.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 0.5% to $195.96.</li>
<li>The&nbsp;Materials&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>) outperformed, up 0.8%; the&nbsp;Energy&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.5%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h3>
Stocks moving on earnings report included:
<ul>
<li>Waste Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>): down 0.6%</li>
<li>Cadence Design Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>): up 4.0%</li>
<li>Brown &amp; Brown, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>): down 6.3%</li>
<li>Nucor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>): up 0.9%</li>
<li>F5 Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>): down 0.9%</li>
<li>Alexandria Real Estate Equities Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>): down 6.7%</li>
<li>Teradyne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>): down 1.0%</li>
<li>S&amp;P Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>): up 2.7%</li>
<li>Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>): up 5.0%</li>
<li>American Tower Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>): up 4.3%</li>
<li>Sherwin-Williams Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>): up 5.2%</li>
<li>Regeneron Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>): down 7.7%</li>
<li>Zebra Technologies Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>): up 6.1%</li>
<li>Ecolab, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>): up 2.2%</li>
<li>Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>): up 1.6%</li>
<li>Labcorp Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>): up 2.3%</li>
<li>Royal Caribbean Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>): down 1.6%</li>
<li>United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>): down 0.5%</li>
<li>General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>): down 0.7%</li>
<li>PayPal Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>): up 1.9%</li>
<li>Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>): up 4.4%</li>
<li>Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>): up 0.8%</li>
<li>Sysco Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYY#NYSE">SYY</a>): up 0.4%</li>
<li>Xylem Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>): up 1.5%</li>
<li>Incyte Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>): up 1.5%</li>
<li>Altria Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>): up 0.7%</li>
<li>Corning, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>): up 2.5%</li>
<li>Paccar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>): down 3.0%</li>
<li>A.O. Smith Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>): up 4.0%</li>
<li>Kraft Heinz Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>): up 0.5%</li>
<li>Entergy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>): down 1.4%</li>
</ul>
Stocks slated to report earnings after the bell include Arch Capital Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>), Booking Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>), Mondelez International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDLZ#NASDAQ">MDLZ</a>), Caesars Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>), Veralto Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLTO#NYSE">VLTO</a>), Seagate Technology Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>), Starbucks Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>), Extendicare Inc. (TSE: EXE), Fair Isaac Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>), Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), Boston Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXP#NYSE">BXP</a>), PPG Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>), Extra Space Storage Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>), Edison International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>), ONEOK, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>), First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), CoStar Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>), Regency Centers Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REG#NASDAQ">REG</a>), Essex Property Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESS#NYSE">ESS</a>), and Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>).
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45074861/us-consumer-expectations-falls-to-13-year-lows-as-recession-fears-inflation-worries-surge">US Consumer Expectations Falls To 13-Year Lows As Recession Fears, Inflation Worries Surge</a></li>
</ul>
Image: Shutterstock

Macro Economic Events

Broad U.S. Equity ETFs

ETFs

ACGL

BKNG

CDNS

CSGP

SPDR Dow Jones Industrial Average ETF Trust

FFIV

FICO

FSLR

INCY

Laboratory Corporation Of America Holdings

MDLZ

PYPL

REGN

SBUX

SPGI

VLTO

Select Sector SPDR-Consumer Discretionary

ZBRA

Stocks Surge And Bond Yields Fall For 6th Day, Oil Prices Drop To $60: What's Driving Markets Tuesday?

D-Wave Quantum shares are trading lower following a report on the stock from Kerrisdale Capital

Press Releases

Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

Legal

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

Trestle Bio Announces Research Collaboration with Humacyte

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

Financing

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Comments

Humacyte

Humacyte (HUMA) Opciones

Humacyte (NASDAQ:HUMA) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL